48 results
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect
8-K
EX-10.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired
8-K
EX-10.1
n5g8 v45zyiay9
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
r6e676q
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-3.1
av08j4sa2mr2
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.3
5cc9de5
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
S-4/A
uyky vn6m6qozcf1
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm